BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27634912)

  • 1. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
    Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
    Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
    Liang X; Li Z; Men Q; Li Y; Li H; Chong T
    Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.
    Dey N; Das F; Ghosh-Choudhury N; Mandal CC; Parekh DJ; Block K; Kasinath BS; Abboud HE; Choudhury GG
    PLoS One; 2012; 7(6):e37366. PubMed ID: 22685542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
    Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
    Wang D; Lu G; Shao Y; Xu D
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28188157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
    Cui Z; Gao H; Yan N; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Wang Q; Kang W; Jin X
    Aging (Albany NY); 2021 Apr; 13(8):12113-12128. PubMed ID: 33848262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
    Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
    Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
    Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
    Ren P; Gong F; Zhang Y; Jiang J; Zhang H
    Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.